Clever Leaves announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics Group. The products are available to medical patients in Australia under ANTG’s “Global Selects” brand portfolio. “As Australia’s medical market continues to grow, working with ANTG marks a significant milestone for us. We are committed to facilitating access to our Colombian flower for those seeking to enhance their quality of life through medicinal products cultivated in our country,” said Andres Fajardo, CEO of Clever Leaves. “Our working relationship with ANTG has been exceptional, as a renowned company for its commitment to research, certified quality standards, and distribution capabilities, all in line with our goal to produce the highest quality, cannabinoid-based products for medical patients worldwide.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CLVR:
- Colombian Flower Is Now Available To Australian Patients Through Strategic Partnership Between Clever Leaves And Australian Natural Therapeutics Group
- Clever Leaves completes sale of assets in Portugal for EUR2.5M
- Clever Leaves Completes Sale of Processing Assets in Portugal to Curaleaf International Subsidiary
- Clever Leaves and Astrasana Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland